##  [Real-world data show Novartis drug Promacta® improves outcomes for ITP patients compared to other second-line therapies](/us-en/news/media-releases/real-world-data-show-novartis-drug-promacta-improves-outcomes-itp-patients-compared-other-second-line-therapies-0 "Real-world data show Novartis drug Promacta® improves outcomes for ITP patients compared to other second-line therapies") 

  Dec 02, 2018